Since these key peptides and proteins play important roles in cognitive performance, and there are few studies to examine the plasma levels of Aβ42, tau, BDNF, and p-tau181 in patients after stroke through longitudinal follow-up, the purpose of this study was to investigate whether these blood with imaging markers can improve the prediction for PSCI. The gene discussed is BDNF; the disease is Stroke.